Concepedia

Paul Angell

PA

Statistics

Publications

6

Citations

115

H-Index

6

Active since

1990

Affiliations

Pfizer (United States)(Current)

Paul Angell is an author at Pfizer (United States) specializing in natural sciences, chemistry, and organic chemistry.

Publications per year

1990–2012

6

Publications

6

Indium (III) mediated Markovnikov addition of malonates and β-ketoesters to terminal alkynes and the formation of Knoevenagel condensation products

Ji Zhang, Peter G. Blazecka, Paul Angell et al. · Tetrahedron · 2005 · 31 citations

, , +6

An efficient, highly stereoselective synthesis of (+)-castanospermine

Peter B. Anzeveno, Paul Angell, Laura J. Creemer et al. · Tetrahedron Letters · 1990 · 26 citations

, , +7

Indium(III)-Catalyzed Addition of Diethyl Acetamidomalonate to Terminal Alkynes:  An Efficient Approach to β-Branched α-Amino Acids

Paul Angell, Peter G. Blazecka, Mark Lovdahl et al. · The Journal of Organic Chemistry · 2007 · 19 citations

, , +9

Mucohalic acid in Lewis acid catalyzed Mukaiyama aldol reaction: a concise method for highly functionalized γ-substituted γ-butenolides

Paul Angell, Ji Zhang, Daniel T. Belmont et al. · Tetrahedron Letters · 2005 · 14 citations

, , +8

Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarring

Mark L. Boys, Feng Bian, James B. Kramer et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 13 citations · Full text

, , +6

1–5 of 6